Microlesion Effect as a Predictor of the Effectiveness of Subthalamic Deep Brain Stimulation for Parkinson's Disease

Stereotactic and Functional Neurosurgery

Volumn 91, Issue 1, 2013, Pages 12-17

  Tykocki, Tomasz ^a   Nauman, Paweł ^a   Koziara, Henryk ^b   Mandat, Tomasz ^b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Deep brain stimulation; Microlesion effect; Parkinson's disease; Subthalamic nucleus

Indexed keywords

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; DISEASE DURATION; ELECTRODE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DEVELOPMENT; PARKINSON DISEASE; POSTOPERATIVE PERIOD; RATING SCALE; SUBTHALAMUS; SYMPTOM; UNITED PARKINSON DISEASE RATING SCALE;

ANTIPARKINSON AGENTS; COMBINED MODALITY THERAPY; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; FEMALE; FOLLOW-UP STUDIES; GLOBUS PALLIDUS; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 84868693899     PISSN: 10116125     EISSN: 14230372     Source Type: Journal    
DOI: 10.1159/000342161     Document Type: Article

References (32)

1. Benabid AL, Chabardes S, Mitrofanis J, Pollak P: Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009; 8: 67-81
2. Benabid AL, Pollak P, Gross C, Hoffmann D, Benazzouz A, Gao DM, Laurent A, Gentil M, Perret J: Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg 1994; 62: 76-84
3. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL: Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339: 1105-1111
4. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934
5. Pahwa R, Wilkinson SB, Overman J, Lyons KE: Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow-up. J Neurosurg 2003; 99: 71-77
6. Deuschl G, Schade-Brittinger C, Krack P, et al: A randomised trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908
7. Mann JM, Foote KD, Garvan CW, et al: Brain penetration effects of microelectrodes and DBS leads in STN or GPI. J Neurol Neurosurg Psychiatry 2009; 80: 794-797
8. Maltête D, Chastan N, Derrey S, Debono B, Gérardin E, Lefaucheur R, Mihout B, Hannequin D: Microsubthalamotomy at day 3: screening for determinants. Mov Disord 2009; 24: 286-289
9. Maltête D, Derrey S, Chastan N, Debono B, Gérardin E, Fréger P, Mihout B, Menard JF, Hannequin D: Microsubthalamotomy: an immediate predictor of long-term subthalamic stimulation efficacy in Parkinson disease. Mov Disord 2008; 23: 1047-1050
10. Cersosimo MG, Raina GB, Benarroch EE, Piedimonte F, Alemán GG, Micheli FE: Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia. Mov Disord 2009; 24: 1488-1493
11. Granziera C, Pollo C, Russmann H, Staedler C, Ghika J, Villemure JG, Burkhard PR, Vingerhoets FJ: Sub-acute delayed failure of subthalamic DBS in Parkinson's disease: the role of micro-lesion effect. Parkinsonism Relat Disord 2008; 14: 109-113
12. Defer GL, Widner H, Marié RM, Rémy P, Levivier M: Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999; 14: 572-584
13. Mandat T, Tykocki T, Koziara H, Koziorowski D, Brodacki B, Rola R, Bonicki W, Nauman P: Subthalamic deep brain stimulation for the treatment of Parkinson disease. Neurol Neurochir Pol 2011; 45: 32-36
14. Chang SY, Shon YM, Agnesi F, Lee KH: Microthalamotomy effect during deep brain stimulation: potential involvement of adenosine and glutamate efflux. Conf Proc IEEE Eng Med Biol Soc 2009: 3294-3297
15. Nedergaard M: Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 1994; 263: 1768-1771
16. Bezzi P, Vesce S, Panzarasa P, Volterra A: Astrocytes as active participants of glutamatergic function and regulators of its homeostasis. Adv Exp Med Biol 1999; 468: 69-80
17. de la Fuente-Fernández R, Schulzer M, Stoessl AJ: The placebo effect in neurological disorders. Lancet Neurol 2002;i:85-91
18. de la Fuente-Fernández R, Schulzer M, Stoessl AJ: Placebo mechanisms and reward circuitry: clues from Parkinson's disease. Biol Psychiatry 2004; 56: 67-71
19. de la Fuente-Fernández R, Phillips AG, Zamburlini M, Sossi V, Calne DB, Ruth TJ, Stoessl AJ: Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 2002; 136: 359-363
20. Mercado R, Constantoyannis C, Mandat T, Kumar A, Schulzer M, Stoessl AJ, Honey CR: Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation. Mov Disord 2006; 21: 1457-1461
21. de la Fuente-Fernández R: Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease. Parkinsonism Relat Disord 2004; 10: 125-127
22. Bickel S, Alvarez L, Macias R, Pavon N, Leon M, Fernandez C, Houghton DJ, Salazar S, Rodríguez-Oroz MC, Juncos J, Guridi J, Delong M, Obeso JA, Litvan I: Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 535-539
23. Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA: Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain 2005; 128: 570-583
24. Deuschl G, Herzog J, Kleiner-Fisman G, Kubu C, Lozano AM, Lyons KE, Rodriguez-Oroz MC, Tamma F, Tröster AI, Vitek JL, Volkmann J, Voon V: Deep brain stimulation: postoperative issues. Mov Disord 2006; 21(suppl 14):S219-S237
25. Eckert T, Tang C, Eidelberg D: Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 2007; 6: 926-932
26. Feigin A, Kaplitt MG, Tang C, Lin T, Mattis P, Dhawan V, During MJ, Eidelberg D: Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci USA 2007; 27: 19559-19564
27. Pourfar M, Tang C, Lin T, Dhawan V, Kaplitt MG, Eidelberg D: Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET. J Neurosurg 2009; 110: 1278-1282
28. Coubes P, Roubertie A, Vayssiere N, Hemm S, Echenne B: Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet 2000; 355: 2220-2221
29. Sudhyadhom A, Bova FJ, Foote KD, Rosado CA, Kirsch-Darrow L, Okun MS: Limbic, associative, and motor territories within the targets for deep brain stimulation: potential clinical implications. Curr Neurol Neurosci Rep 2007; 7: 278-289
30. Derrey S, Lefaucheur R, Chastan N, Gérardin E, Hannequin D, Desbordes M, Maltête D: Alleviation of off-period dystonia in Parkinson disease by a microlesion following subthalamic implantation. J Neurosurg 2010; 112: 1263-1266
31. Charles PD, Van Blercom N, Krack P, Lee SL, Xie J, Besson G, Benabid AL, Pollak P: Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002; 59: 932-934
32. Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, Lin SZ, Chen SY: Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short-and long-term effects. Stereotact Funct Neurosurg 2009; 87: 241-248.